Recombinant LOXL2 (Simtuzumab Biosimilar) 抗体
Our Local Distributor
北京 101111
Quick Overview for Recombinant LOXL2 (Simtuzumab Biosimilar) 抗体 (ABIN7675789)
抗原
抗体类型
适用
宿主
克隆类型
标记
应用范围
-
-
Expression System
- CHO Cells
-
原理
- Anti-LOXL2 Reference Antibody (simtuzumab)
-
序列
- QVQLVQSGAE VKKPGASVKV SCKASGYAFT YYLIEWVRQA PGQGLEWIGV INPGSGGTNY NEKFKGRATI TADKSTSTAY MELSSLRSED TAVYFCARNW MNFDYWGQGT TVTVSSASTK GPSVFPLAPC SRSTSESTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP AVLQSSGLYS LSSVVTVPSS SLGTKTYTCN VDHKPSNTKV DKRVESKYGP PCPPCPAPEF LGGPSVFLFP PKPKDTLMIS RTPEVTCVVV DVSQEDPEVQ FNWYVDGVEV HNAKTKPREE QFNSTYRVVS VLTVLHQDWL NGKEYKCKVS NKGLPSSIEK TISKAKGQPR EPQVYTLPPS QEEMTKNQVS LTCLVKGFYP SDIAVEWESN GQPENNYKTT PPVLDSDGSF FLYSRLTVDK SRWQEGNVFS CSVMHEALHN HYTQKSLSLS LGK,DIVMTQTPLS LSVTPGQPAS ISCRSSKSLL HSNGNTYLYW FLQKPGQSPQ FLIYRMSNLA SGVPDRFSGS GSGTDFTLKI SRVEAEDVGV YYCMQHLEYP YTFGGGTKVE IKRTVAAPSV FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC
-
产品特性
- Anti-LOXL2 Reference Antibody (simtuzumab) is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
-
纯度
- >95 %
-
亚型
- IgG4 S228P
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
说明
-
Therapeutic Agents by Target and Mechanism: LOXL2 inhibitors
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
浓度
- 1 mg/mL
-
缓冲液
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
-
储存条件
- 4 °C,-80 °C
-
储存方法
- +4°C,-80°C
-
-
- LOXL2 (Simtuzumab Biosimilar)
-
物质类
- Biosimilar
-
分子量
- 145.5 kDa
-
UniProt
- Q9Y4K0
抗原
-